CDMRP Ovarian Cancer Proteogenomics Research Award

By Dept. of the Army -- USAMRAA
Government Grant





The OCRP Proteogenomics Research Award supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer. The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer. The proposed research question should be innovative and have the potential to make an impact on ovarian cancer.Clinical trials are not allowed under the Proteogenomics Research Award mechanism. The analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged. Preliminary data are not required but are allowed.

Thanks to the funder for their generosity.